How Single-Use Technology Will Be Critical To The Commercialization Of Cell And Gene Therapies

By Timothy Korwan, Director, New Product Introduction, Avantor, Inc.

Scaling up cell & gene therapies from research and development to commercialization is creating a new set of challenges for manufacturers. With the urgent demand of speeding up the market reach for these life-altering innovative therapies a high risk is inherent to implement inefficient workflow processes. This article will demonstrate how adopting innovative single-use solutions for in-process sampling can have a tremendous effect in efficiency and effectiveness to the workflow. Single-use solutions continue to provide productive strategies in effectively scaling up these processes while reducing risks and costs.